Brand vs generic adverse event reporting patterns: An authorized generic‐controlled evaluation of cardiovascular medications
Y. Alatawi; Md. M. Rahman; N. Cheng; J. Qian; P. L. Peissig; R. L. Berg; C. D. Page; R. A. Hansen
Author Information: Department of Health Outcomes Research and Policy
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.